KyungDong Pharm Co., Ltd. releases ‘Solfecin Tablets 5mg, 10mg (Solifenacin Succinate)’, a treatment for overactive bladder symptoms, on July 14, 2017.
Solfecin tablets are an antimuscarinic drug with high selectivity for M3 receptors in the bladder, and have the advantage of having a lower rate of dry mouth compared to existing antimuscarinic drugs. In addition, it shows a greater symptom improvement effect than existing antimuscarinics in reducing urinary urgency, urgency urinary incontinence, and the frequency of urinary incontinence.
It is expected that the launch of Solpecin tablets, along with KyungDong Pharm Co., Ltd.'s Telodine tablets (Tolterodine 2mg), will be helpful in the treatment of patients with overactive bladder.
♤ Product Information ♤
|
Product Name |
Solfecin tablets 5mg |
Solfecin tablets 10mg |
|
Ingredient content |
Solifenacin succinate 5mg |
Solifenacin succinate 10mg |
|
Indications |
Treatment of overactive bladder symptoms such as urge incontinence, frequent urination, and urinary urgency. | |
|
Dosage and usage |
Recommended dose: 5mg once a day, increase up to 10mg once a day if necessary | |
|
Reimbursement Prices |
678 won/tablet |
678 won/tablet |
|
Reimbursement Code |
648103820 |
648103830 |
|
Packaging unit |
30 tablets, 100 tablets |
30 tablets, 100 tablets |
※ Please refer to the product manual for other details such as precautions for use.